heterologous vaccination
Showing 1 - 25 of 3,809
COVID-19 Pandemic Trial (Lyophilized COVID-19 mRNA Vaccine, Sodium chloride)
Not yet recruiting
- COVID-19 Pandemic
- Lyophilized COVID-19 mRNA Vaccine
- Sodium chloride
- (no location specified)
Nov 18, 2022
COVID-19 VACCINE, Covid19 Trial in Argentina (COVID-19 vaccines)
Recruiting
- COVID-19 VACCINE
- Covid19
- COVID-19 vaccines
-
Córdoba, Argentina
- +3 more
Sep 24, 2021
Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)
Completed
- Healthy Adult Volunteers
- ChAdOx1-nCov-19 (Astra-Zeneca)
- SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
-
Taipei City, X, TaiwanNational Taiwan University Hospital
Oct 16, 2022
SARS-CoV2 Infection Trial in Innsbruck (Vaxzevria, Comirnaty)
Recruiting
- SARS-CoV2 Infection
- Vaxzevria
- Comirnaty
-
Innsbruck, Tyrol, AustriaMedical University of Innsbruck
Sep 9, 2021
COVID-19 Trial (GBP510 adjuvanted with AS03, Placebo (Normal Saline))
Not yet recruiting
- COVID-19
- GBP510 adjuvanted with AS03
- Placebo (Normal Saline)
- (no location specified)
Aug 11, 2022
COVID-19 Trial in Cali (VLA 2001)
Not yet recruiting
- COVID-19
- VLA 2001
-
Cali, Valle, ColombiaCentro de Estudios en Infectología Pediátrica
Sep 15, 2022
COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)
Completed
- COVID-19
- CoronaVac/CoronaVac
- CoronaVac/BNT162b2
-
Bizerte, Mateur, Tunisia
- +4 more
Jan 4, 2023
COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)
Active, not recruiting
- COVID-19
- Ad26COVS1
- +3 more
-
Vienna, AustriaMedicial University of Vienna
Apr 12, 2022
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation Trial in Cape Town (Tetanus Toxoid, Reduced Diphtheria
Recruiting
- Pertussis Immunisation
- +3 more
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
-
Cape Town, South Africa
- +2 more
Dec 2, 2022
SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)
Recruiting
- SARS-CoV-2 Infection
- Full dose of Ad26.COV2. 5x10^10vp
- Half dose of Ad26.COV2. 2.5x10^10vp
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022
Measles Vaccine, Hospital Admission, Mortality Trial in Bissau (measles vaccine, Saline)
Enrolling by invitation
- Measles Vaccine
- +3 more
- measles vaccine
- Saline
-
Bissau, Guinea-BissauBandim Health Project
Jan 21, 2022
Multiple Sclerosis Trial in Derby (Homologous booster, Heterologous booster)
Recruiting
- Multiple Sclerosis
- Homologous booster
- Heterologous booster
-
Derby, ConnecticutGriffin Hospital
Jan 23, 2022
Virus Diseases, Hemorrhagic Fever, Ebola, Infections Trial in Kambia (Ad26.ZEBOV, MVA-BN-Filo)
Recruiting
- Virus Diseases
- +10 more
- Ad26.ZEBOV, MVA-BN-Filo
-
Kambia, Sierra LeoneEBOVAC Kambia 1 clinic
Oct 11, 2022
Covid19 Trial in Netherlands (Vaccination once with Janssen vaccine (only priming), Vaccination with Janssen vaccine followed
Recruiting
- Covid19
- Vaccination once with Janssen vaccine (only priming)
- +3 more
-
Amsterdam, Netherlands
- +3 more
Jun 26, 2021
Biomarkers of Trained Immunity Following MMR Vaccination
Completed
- Covid19
- Heterologous stimuli
- Neutralization assay
-
Saint Louis, MissouriWashington University School of Medicine
Nov 24, 2021
COVID-19 (Healthy Volunteers) Trial in Korea, Republic of (SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of
Not yet recruiting
- COVID-19 (Healthy Volunteers)
- SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03
- Normal saline
-
Ansan, Korea, Republic of
- +9 more
Jan 3, 2022
Covid19 Trial in Hamburg (MVA-SARS-2-S vaccinations (days 0 & 28), Comirnaty)
Completed
- Covid19
- MVA-SARS-2-S vaccinations (days 0 & 28)
- Comirnaty
-
Hamburg, GermanyCTC North GmbH & Co KG at the University Medical Center Hamburg-
Nov 4, 2021
Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain
Completed
- SARS-CoV 2 Infection
- Covid19
- BBIBP-CorV
- BNT162b2
-
Manama, BahrainRoyal College of Surgeons in Ireland - Bahrain
Oct 25, 2021
Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)
Not yet recruiting
- Ebola Virus Disease
- Zabdeno® booster
- Ervebo® booster
-
Goma, Congo, The Democratic Republic of the
- +1 more
Nov 6, 2023
Dengue Virus Trial in Silver Spring (TDENV-PIV, TDENV-LAV F17)
Active, not recruiting
- Dengue Virus
- TDENV-PIV
- TDENV-LAV F17
-
Silver Spring, MarylandWRAIR, Clinical Trials Center
Mar 25, 2021
Measles Vaccination, Oral Polio Vaccine, Non-specific/Heterologous Effects of Vaccines Trial in Bissau (Measles vaccine, Oral
Unknown status
- Measles Vaccination
- +5 more
- Measles vaccine
- Oral polio vaccine
-
Bissau, Guinea-BissauBandim Health Project
Feb 28, 2021
Serology After BBIBP-CorV Inactivated Vaccine Combined With
Completed
- Basic BBIBP-CorV Vaccination is Not as Effective as BNT162b
- BBIBP-CorV and/or BNT162b2 vaccine
-
Debrecen, Hajdu-Bihar, HungaryUniversity of Debrecen
Sep 15, 2022
COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)
Active, not recruiting
- COVID-19
- Breakthrough Infection
- BNT162b2
- +2 more
-
Taoyuan city, TaiwanChang Gung Memorial Hospital
Jul 21, 2022